08:00   Registration, partnering meetings and networking in the exhibition hall

08:30   Welcome and introduction
Johan Rockberg,  Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

08:35   Creating a fertile soil for clinical research at Karolinska University Hospital
Olof Akre, Professor of cancer surgery & Director of research, education, and development, Karolinska University Hospital
            

09:00    Toward person-centric molecular health perspectives
Jochen Schwenk, Professor of Translational Proteomics, KTH Royal Institute of Technology

09:25    Antibodies work in teams:
Enhancing the natural phenomenon of IgG hexamerization to drive antibody effector functions
Esther Breij, Vice President, Global Head of Translational Research, Genmab

09:50    Coffee, partnering meetings and networking in the exhibition hall 
           

10:30    Decode and target the non-random metastatic behaviors of adult and childhood cancer
Catharina Hagerling, Associate Professor of Experimental Pathology, Lund University     
         

10:55    How to build an R&D organization with a diverse CNS drug discovery pipeline   
Pontus Forsell, Co-founder & Head of Discovery and Research, AlzeCure Pharma

11:20    Pitfalls along the drug development path
Jenny Blomqvist, Senior Analytical Scientist, RISE Research Institutes of Sweden
Lina Nyström, Formulation Scientist, RISE Research Institutes of Sweden  
             

11:45    Unlocking the potential of academia-industry collaboration
Fadwa Benkessou, PhD, Academia-Industry Alliance Manager, Karolinska Institutet      
     

12:10     Lunch, partnering meetings and networking in the exhibition hall                            

13:10    Body’s own defenses shape virus tropism in the brain          
Anna Överby Wernstedt, Professor of Immunology, Umeå University 
 

13:35     Synthetic glycopolymers target primary haemostasis: therapeutic potential in bleeding disorders
Magnus Grenegård, Professor in Physiology, Örebro University

14:00     Intrinsic Activated Thrombin generation assays for evaluation of the haemostatic system: Efficacy and monitoring of different Hemophilia A replacement therapies
Henri M.H. Spronk, PhD, CEO, Coagulation Profile Floor Heubel-Moenen, MD, PhD, Maastricht University
  

14:25     Coffee, partnering meetings and networking in the exhibition hall

15:05     A human pan-disease blood atlas based on next generation blood profiling
Mathias Uhlén, Professor of Microbiology, Science for Life Laboratory, KTH Royal Institute of Technology

15:30     AI in precision health: advancing metabolic health screening and monitoring
Peter Vesterberg, Founder & CEO, Saluto

15:55    Summary and conclusion
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

16:00    End of programme